To lower your risk of obesity, our read is that focusing on whole, unprocessed foods and mindful eating strategies is crucial, alongside understanding the physiological and neurological factors influencing weight.
Our read is that modern processed foods are a significant contributor to obesity and related health issues, with Paul Saladino noting their potential role in conditions like cancer, heart disease, and type 2 diabetes. Conversely, a diet rich in micronutrients, protein, or real animal fat can drive satiety, which Paul Saladino emphasizes as crucial for achieving and maintaining a caloric deficit for weight loss. Andrew Huberman and Rhonda Patrick highlight that successful dieters show an increase in the size of their anterior mid-cingulate cortex, suggesting a neurological component to dietary success.
Paul Saladino suggests that satiety, driven by micronutrients and secondarily by protein or real animal fat, is crucial for achieving and maintaining a caloric deficit for weight loss. Andrew Huberman notes that perceiving work as exercise can lead to positive physiological changes including weight loss and improved body composition, even without changes in diet or actual work intensity. Rhonda Patrick indicates that time-restricted feeding can lead to physiological improvements in obese mice, with blood biomarkers returning to near-normal ranges.
Our experts disagree on the efficacy of certain weight loss strategies; Paul Saladino states that ultra-processed foods contribute to Americans being overweight and unhealthy and increase hunger, while Peter Attia notes that exercise is not an effective tool for weight loss, with caloric restriction playing a greater role. Paul Saladino also argues that diets based on calorie restriction fail due to a misunderstanding of human digestion and biochemistry, and that severe calorie restriction leads to weight regain. Andrew Huberman suggests that the common fitness approach of prioritizing aesthetics and hypertrophy through long, slow cardio for fat loss is not optimal, and that the suggestion that everyone with a certain BMI should be on new weight-loss drugs is incorrect and will not lead to long-term health. Peter Attia also points out that purely restrictive bariatric procedures are less effective than malabsorptive procedures because they do not prevent caloric intake of liquids.
The verdict would change if there were new findings on the long-term risks of weight loss drugs for minor health compromises, which Peter Attia notes are not sufficiently understood. Additionally, a better understanding of whether sustaining excess body fat for 20 years inevitably leads to a decline in metabolic health, as Peter Attia suggests, would also alter the verdict.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.
Animal-model results don't translate to the human protocol being recommended.